학술논문
BMS-986158, a Potent BET Inhibitor, As Monotherapy and in Combination with Ruxolitinib or Fedratinib in Intermediate- or High-Risk Myelofibrosis: First Results from a Phase 1/2 Study
Document Type
Abstract
Author
Ayala, Rosa ; Lopez, Nieves ; Shacham Abulafia, Adi ; Alwan, Maan ; Yannakou, Costas K. ; Raman, Indu ; Ribrag, Vincent; Fong, Chun Yew; Volchek, Yulia ; Bonifacio, Massimiliano ; Tucci, Alessandra ; Kiladjian, Jean-Jacques; Chang, Henry ; Das, Sharmila ; Wu, Bin ; Ravindran, Palanikumar ; Shan, Vivian ; Wang, Guan ; Esposito, Oriana ; Liu, Yu ; Nikolova, Zariana ; Tehlirian, Christopher ; Coker, Shodeinde ; Lavie, David
Source
In Blood 15 November 2022 140 Supplement 1:9665-9667
Subject
Language
ISSN
0006-4971